Clinical trials
Withdrawn Myocardial Infarction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Helios Health Institute GmbH | 2 |
| Imperial College London | 2 |
| NYU Langone Health | 2 |
| RWTH Aachen University | 2 |
| UMC Utrecht | 2 |
| Albert Einstein College of Medicine | 1 |
| Aristotle University Of Thessaloniki | 1 |
| Biotronik SE & Co. KG | 1 |
| CardiacAssist, Inc. | 1 |
| Cedars-Sinai Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Infarction | 49 |
| Cardiovascular Diseases | 9 |
| Acute Coronary Syndrome | 7 |
| Heart Diseases | 6 |
| Coronary Artery Disease | 5 |
| Heart Failure | 5 |
| Myocardial Ischemia | 5 |
| ST Elevation Myocardial Infarction | 5 |
| Stroke | 5 |
| Angina, Unstable | 3 |
Trials
Showing 76 to 49 of 49. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.